The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975–1999
Open Access
- 8 August 2005
- Vol. 104 (6) , 1149-1157
- https://doi.org/10.1002/cncr.21285
Abstract
BACKGROUND: Temporal comparisons of case survival are commonly used to assess improvement in cancer treatment at the population level. However, such comparisons may be confounded by secular trends in disease prognosis, even within conventional stage categories. The objective of the current study was to characterize within‐stage migration of tumor size in breast carcinoma, and to estimate the effect of this shift on reported breast carcinoma survival.METHODS: Population‐based Surveillance, Epidemiology, and End Results (SEER) cancer registry data were used to evaluate secular trends in tumor size at the time of diagnosis and relative survival among localized and regional invasive breast carcinoma patients diagnosed between 1975–1999. Outcomes were stage‐specific tumor size distribution, 5‐year relative survival, relative survival standardized to the tumor size distribution of the cohort diagnosed between 1975–1979, and the percentage of improvement in relative survival attributable to shifts in tumor size distribution.RESULTS: Within each stage category, the proportion of smaller tumors increased significantly over time. Comparing patients diagnosed between 1995–1999 with those diagnosed between 1975–1979, within‐stage migration of tumor size accounted for 61% and 28%, respectively, of the relative survival increases noted in localized and regional breast carcinoma.CONCLUSIONS: The tumor size distribution of incident breast carcinomas in SEER has shifted toward smaller tumors. A substantial fraction of the improvement in breast carcinoma survival noted since 1975 may be attributable to within‐stage migration of tumor size. Cancer 2005. © 2005 American Cancer Society.Keywords
This publication has 39 references indexed in Scilit:
- Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatmentBritish Journal of Cancer, 2004
- Trends in Use of Adjuvant Multi-Agent Chemotherapy and Tamoxifen for Breast Cancer in the United States: 1975-1999JNCI Journal of the National Cancer Institute, 2002
- Progress in Cancer Screening Over a Decade: Results of Cancer Screening From the 1987, 1992, and 1998 National Health Interview SurveysJNCI Journal of the National Cancer Institute, 2001
- Recent improvement in survival of breast cancer patients in Saarland, Germany.British Journal of Cancer, 1998
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment?BMJ, 1997
- Recent Trends in U.S. Breast Cancer Incidence, Survival, and Mortality RatesJNCI Journal of the National Cancer Institute, 1996
- The Effects of Early Treatment, Lead Time and Length Bias on the Mortality Experienced by Cases Detected by ScreeningInternational Journal of Epidemiology, 1982
- National Institutes of Health/National Cancer Institute Consensus Development Meeting on Breast Cancer Screening: Issues and Recommendations 1JNCI Journal of the National Cancer Institute, 1978